Loading mutual fund details…
DSP Global Innovation Overseas Equity Omni FoF - Regular - Growth is a fof scheme managed by DSP Mutual Fund. Three-year compounded annual return is 27.99%, placing it in the 66th percentile of FoF peers. It has ranked in the top half of its category for 3 of the last 3 reported years. Risk-adjusted return (Sharpe ratio) is 0.00. The total expense ratio is 2.03% on assets of ₹1,132Cr. The fund is currently managed by Kaivalya Nadkarni, appointed within the last year.
Lower is better.
| Holding | Sector | Weight |
|---|
Point-in-time CAGRs cherry-pick a single start date. The chart below shows the distribution of every possible rolling start over the fund's history, so you see the range of investor outcomes — not just one date's number.
Backtested SIP outcomes across both rolling-window scenarios and named historical stress events (COVID, Election uncertainty, Russia/Ukraine, etc.), plus per-manager alpha during their tenure on this scheme.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not indicative of future results. MintByte is an AMFI-registered Mutual Fund Distributor (ARN-314872) and APMI member (APRN-01658). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Star ratings on this page reflect a 3-year category-quartile position computed in-house and are educational only.
Mutual fund schemes are subject to market risk. Read all scheme-related documents carefully before investing. Past performance is not indicative of future results. MintByte is an AMFI-registered mutual fund distributor (ARN-314872). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Not investment advice. Methodology · How we earn.
In-house derivations using 3-year daily NAV vs benchmark. See methodology.
| Bluebox Global Technology Fund | Others | 38.75% |
| iShares NASDAQ 100 UCITS ETF | Others | 28.54% |
| IVZ NASDAQ 100 EW ACC | Others | 12.26% |
| KRANESHARES CSI CHINA INTRNT | Others | 11.16% |
| Fidelity Select Medical Technology And Devices Portfolio | Others | 3.37% |
| Bluebox Precision Medicine Fund | Others | 2.23% |
How crowded into the same stocks is this fund vs the largest fund in its category?
Category leader = highest-AUM scheme in the same SEBI category. A high overlap-of-weight number means the fund is concentrated into the same names as the leader (crowded); a low one means it's genuinely differentiated.
Each cell is one year. Q1 = top quartile within the AMFI category for that period. Cell label is the last two digits of the year.
Top-10 weight 96.3% means the manager bets the fund's outcome on a small basket. Effective-N is the inverse Herfindahl index — a measure of "how many positions effectively drive the fund" after weighting. Category: FoF.
Compounding maths on a notional ₹10 lakh lumpsum at 12% gross annual return. Green bar is what you'd have without the fee; red overlay is the fee drag. Fee is constant in this scenario — actual outcomes depend on real returns and any future TER changes.
Alpha is the annualised excess return vs benchmark over the manager's tenure on this scheme. Beat-benchmark = total return beat the index over the same window.